慢性心力衰竭患者采用美托洛尔联合芪苈强心胶囊治疗的效果分析(1)
【摘 要】
目的:觀察慢性心力衰竭患者经美托洛尔联合芪苈强心胶囊治疗的效果。方法:选取我院2017年6月~2018年7月接收的82例慢性心力衰竭患者作为治疗对象,以随机数字分组法将82例患者均分为观察组及对照组2组,观察组41例患者均给予美托洛尔联合芪苈强心胶囊药物治疗方案,对照组41例患者均单纯实施美托洛尔药物方案,观察2组患者的疗效水平差异。结果:经不同药物方案治疗后,观察组41例慢性心力衰竭患者的心功能指标相比同期对照组41例患者改善明显,且治疗总有效率显著较高,P<0.05,组间差异具有统计学意义。结论:慢性心力衰竭患者采用美托洛尔联合芪苈强心胶囊治疗方案,具有确切的临床疗效,可有效改善患者心功能,强化预后生活质量,值得临床综合应用推广。
【关键词】芪苈强心胶囊;美托洛尔;慢性心衰;疗效
Effect analysis of the treatment of chronic heart failure patients with metopolol combined withLi strong heart capsule
Abstract Objective:
To observe the effect of treatment of chronic heart failure patients by metopolol combined with stilbene Li strong heart capsule capsules. Methods Select our hospital from June 2017 to July 2018 received 82 cases of chronic heart failure patients as treatment object, in a random digital grouping 82 patients were divided into observation group and control group 2 groups, 41 cases observation group were given metoprolol combined strong heart capsule drug treatment, control group and 41 patients with metoprolol drug solution, to observe the curative effect of two groups patients level difference. Results After treatment with different drug regimens, the cardiac function indexes of 41 patients with chronic heart failure in the observation group were significantly improved compared with the 41 patients in the control group at the same time, and the total treatment efficiency was also significantly higher, P<0.05, showing statistically significant difference between the groups. Conclusion:The treatment of chronic heart failure with metoprolol combined with Li strong heart capsule capsules has definite clinical efficacy, can effectively improve the cardiac function and enhance the prognosis quality of life, and is worthy of clinical application and promotion.
Key words: Stilbene Li strong heart capsule; Metoprolol; Chronic heart failure; Effect
【中图分类号】 R248.3
【文献标识码】 A
【文章编号】 1672-3783(2019)02-03-038-01
慢性心力衰竭是心内科临床较常见的一类疾病,主要致病因与心肌梗死、血流动力学负荷过重、炎症反应等情况所致的心肌功能变化相关,最终造成患者心室泵血、充盈功能的低下,诱发心力衰竭疾病的发生。基于慢性心力衰竭致病因素复杂,治疗难度相对较高,且易诱发患者不良疾病后果,还需临床给予足够的关注重视[1]。本研究为选择慢性心力衰竭患者治疗适用的药物治疗方案,有效强化患者心功能水平及生活质量,系统纳入了我院2017年6月以来接收的41例同病症患者作为治疗对象,给予了美托洛尔联合芪苈强心胶囊治疗方案,且为便于药物疗效观察,特选取了我院同期接收的另41例慢性心力衰竭患者设为对照组,给予了美托洛尔单药治疗方案,进而以对比分析法实施了2组患者疗效差异的比较,现将研究结果具体报道如下。
1 一般资料与方法
1.1 一般资料
选取我院2017年6月~2018年7月接收的82例慢性心力衰竭患者作为治疗对象,82例患者均经影像学诊断、体格检查确诊,符合《急慢性心力衰竭诊治指南》(2016)中关于慢性心力衰竭疾病的诊断标准。所有患者均存在典型心衰表现,以不同程度的呼吸困难、乏力、心绞痛为主诉表现;系统筛除急性心力衰竭、心梗患者及严重脏器合并症患者、妊娠哺乳期患者。治疗前均由家属陪同签署知情同意书,表示自愿纳入本研究。以随机数字分组法实施82例患者分组,共分为观察组、对照组2组。观察组41例患者中,男性20例,女性21例,年龄区间44~75岁,平均(59.4±11.5)岁,心功能分级:II级17例、III级14例,IV级10例。对照组41例患者中,男性22例,女性19例,年龄区间46~77岁,平均(58.8±12.4)岁,心功能分级:II级18例,III级14例,IV级9例。本研究2组患者的性别、年龄、病情等资料无显著差异,P>0.05,存在可比性。, http://www.100md.com(谭欣 龚晓芳 李本福)
目的:觀察慢性心力衰竭患者经美托洛尔联合芪苈强心胶囊治疗的效果。方法:选取我院2017年6月~2018年7月接收的82例慢性心力衰竭患者作为治疗对象,以随机数字分组法将82例患者均分为观察组及对照组2组,观察组41例患者均给予美托洛尔联合芪苈强心胶囊药物治疗方案,对照组41例患者均单纯实施美托洛尔药物方案,观察2组患者的疗效水平差异。结果:经不同药物方案治疗后,观察组41例慢性心力衰竭患者的心功能指标相比同期对照组41例患者改善明显,且治疗总有效率显著较高,P<0.05,组间差异具有统计学意义。结论:慢性心力衰竭患者采用美托洛尔联合芪苈强心胶囊治疗方案,具有确切的临床疗效,可有效改善患者心功能,强化预后生活质量,值得临床综合应用推广。
【关键词】芪苈强心胶囊;美托洛尔;慢性心衰;疗效
Effect analysis of the treatment of chronic heart failure patients with metopolol combined withLi strong heart capsule
Abstract Objective:
To observe the effect of treatment of chronic heart failure patients by metopolol combined with stilbene Li strong heart capsule capsules. Methods Select our hospital from June 2017 to July 2018 received 82 cases of chronic heart failure patients as treatment object, in a random digital grouping 82 patients were divided into observation group and control group 2 groups, 41 cases observation group were given metoprolol combined strong heart capsule drug treatment, control group and 41 patients with metoprolol drug solution, to observe the curative effect of two groups patients level difference. Results After treatment with different drug regimens, the cardiac function indexes of 41 patients with chronic heart failure in the observation group were significantly improved compared with the 41 patients in the control group at the same time, and the total treatment efficiency was also significantly higher, P<0.05, showing statistically significant difference between the groups. Conclusion:The treatment of chronic heart failure with metoprolol combined with Li strong heart capsule capsules has definite clinical efficacy, can effectively improve the cardiac function and enhance the prognosis quality of life, and is worthy of clinical application and promotion.
Key words: Stilbene Li strong heart capsule; Metoprolol; Chronic heart failure; Effect
【中图分类号】 R248.3
【文献标识码】 A
【文章编号】 1672-3783(2019)02-03-038-01
慢性心力衰竭是心内科临床较常见的一类疾病,主要致病因与心肌梗死、血流动力学负荷过重、炎症反应等情况所致的心肌功能变化相关,最终造成患者心室泵血、充盈功能的低下,诱发心力衰竭疾病的发生。基于慢性心力衰竭致病因素复杂,治疗难度相对较高,且易诱发患者不良疾病后果,还需临床给予足够的关注重视[1]。本研究为选择慢性心力衰竭患者治疗适用的药物治疗方案,有效强化患者心功能水平及生活质量,系统纳入了我院2017年6月以来接收的41例同病症患者作为治疗对象,给予了美托洛尔联合芪苈强心胶囊治疗方案,且为便于药物疗效观察,特选取了我院同期接收的另41例慢性心力衰竭患者设为对照组,给予了美托洛尔单药治疗方案,进而以对比分析法实施了2组患者疗效差异的比较,现将研究结果具体报道如下。
1 一般资料与方法
1.1 一般资料
选取我院2017年6月~2018年7月接收的82例慢性心力衰竭患者作为治疗对象,82例患者均经影像学诊断、体格检查确诊,符合《急慢性心力衰竭诊治指南》(2016)中关于慢性心力衰竭疾病的诊断标准。所有患者均存在典型心衰表现,以不同程度的呼吸困难、乏力、心绞痛为主诉表现;系统筛除急性心力衰竭、心梗患者及严重脏器合并症患者、妊娠哺乳期患者。治疗前均由家属陪同签署知情同意书,表示自愿纳入本研究。以随机数字分组法实施82例患者分组,共分为观察组、对照组2组。观察组41例患者中,男性20例,女性21例,年龄区间44~75岁,平均(59.4±11.5)岁,心功能分级:II级17例、III级14例,IV级10例。对照组41例患者中,男性22例,女性19例,年龄区间46~77岁,平均(58.8±12.4)岁,心功能分级:II级18例,III级14例,IV级9例。本研究2组患者的性别、年龄、病情等资料无显著差异,P>0.05,存在可比性。, http://www.100md.com(谭欣 龚晓芳 李本福)